Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralymphatic vs Subcutaneous Immunotherapy for Grass Pollen Allergy
NCT00470457Phase 2Completed
- Sponsor
- University of Zurich
- Start
- Jun 2001
- Modality
- Subcutaneous Immunotherapy, Sublingual Immunotherapy
- Countries
- 1
01
Overview
A Phase 2 trial of grass pollen allergen extract in allergic rhinoconjunctivitis (ARC), sponsored by University of Zurich. Started Jun 2001; status: completed.
02
Drugs
grass pollen allergen extract
03
Conditions
allergic rhinoconjunctivitis (ARC)
Beyond the preview
Go deeper on NCT00470457.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00470457.